| Molecular formula | C194H304N48O61 |
|---|
| Molecular weight | 4285 g/mol |
|---|
| Registered trials | 15 |
|---|
| PubChem CID | 162625103 |
|---|
What Ecnoglutide Is
Ecnoglutide is a large synthetic peptide compound (molecular formula C194H304N48O61) identified in chemical databases under PubChem CID 162625103. It has no FDA-approved label, and no brand name, indication, or mechanism description is available from regulatory sources. It is currently classified as an unapproved research compound, meaning it has not been reviewed or authorized by the FDA for any use in patients.
Trial Footprint
Ecnoglutide has been registered in 15 clinical trials to date. Several of these are studying the compound, sometimes listed under related names such as XW003 or VRB-101, in people with obesity or overweight and associated conditions.
Sampled trials include a study evaluating ecnoglutide injection in obese participants with knee osteoarthritis, a study of the compound in obese participants with obstructive sleep apnea who are also receiving positive airway pressure therapy, and a study assessing weekly oral dosing for weight maintenance among participants with obesity or overweight and weight-related comorbidities. These trials remain in active stages, with recruitment or ongoing participant follow-up underway.
FAQ
No. Ecnoglutide is currently classified as an unapproved research compound with no FDA-approved label, brand name, or indication. Any use outside of registered clinical trials is not supported by regulatory approval.
Based on registered trials, ecnoglutide is being studied in people with obesity or overweight, including those with related conditions such as knee osteoarthritis and obstructive sleep apnea. These studies are ongoing and do not establish proven benefit.
Ecnoglutide appears in 15 registered clinical trials as of the most recent data. Some of these trials refer to the compound under alternate names, including XW003 and VRB-101.
Yes. Trial records show the compound has also been referenced as XW003 and VRB-101 in different study registrations, though ecnoglutide is the primary compound name used here.
Ecnoglutide is a large peptide with the molecular formula C194H304N48O61, cataloged under PubChem CID 162625103. Detailed mechanism of action information is not available in the absence of an approved label.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem ClinicalTrials.gov
Updated 2026-09-26